The human microcirculation: regulation of flow and beyond

DD Gutterman, DS Chabowski, AO Kadlec… - Circulation …, 2016 - Am Heart Assoc
The microcirculation is responsible for orchestrating adjustments in vascular tone to match
local tissue perfusion with oxygen demand. Beyond this metabolic dilation, the …

[HTML][HTML] The “no reflow” phenomenon following acute myocardial infarction: mechanisms and treatment options

S Kaul - Journal of Cardiology, 2014 - Elsevier
If 'no reflow'is observed within 45 min of reperfusion using balloon angioplasty or stent, it is
probably related to microthromboemboli, which may also contribute to the extension of the …

Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction

RW Harrison, A Aggarwal, F Ou, LW Klein… - The American journal of …, 2013 - Elsevier
Previous studies describing the no-reflow phenomenon in patients with acute myocardial
infarction (AMI) undergoing percutaneous coronary intervention (PCI) were largely confined …

Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group

KS Rathod, S Koganti, MB Iqbal, AK Jain… - … Heart Journal: Acute …, 2018 - academic.oup.com
Background Cardiogenic shock remains a major cause of morbidity and mortality in patients
with ST-segment elevation myocardial infarction. We aimed to assess the current trends in …

Mechanism and potential treatment of the “no reflow” phenomenon after acute myocardial infarction: role of pericytes and GPR39

C Methner, Z Cao, A Mishra… - American Journal of …, 2021 - journals.physiology.org
The “no reflow” phenomenon, where the coronary artery is patent after treatment of acute
myocardial infarction (AMI) but tissue perfusion is not restored, is associated with worse …

A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by …

K Hibi, K Kozuma, S Sonoda, T Endo, H Tanaka… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The aim of this study was to evaluate the utility of distal protection during
percutaneous coronary intervention (PCI) in patients with acute coronary syndromes at high …

Passive heat therapy protects against endothelial cell hypoxia‐reoxygenation via effects of elevations in temperature and circulating factors

VE Brunt, K Wiedenfeld‐Needham… - The Journal of …, 2018 - Wiley Online Library
Key Points Accumulating evidence indicates that passive heat therapy (chronic use of hot
tubs or saunas) has widespread physiological benefits, including enhanced resistance …

Hepatoprotective effect of curcumin nano-lipid carrier against cypermethrin toxicity by countering the oxidative, inflammatory, and apoptotic changes in wistar rats

S Hussain, M Ashafaq, S Alshahrani, IAM Bokar… - Molecules, 2023 - mdpi.com
This study investigated the potential hepatoprotective activity of curcumin-incorporated nano-
lipid carrier (Cur-NLC) against cypermethrin (Cyp) toxicity in adult Wistar male rats. All …

Inflammation during percutaneous coronary intervention—prognostic value, mechanisms and therapeutic targets

B Tucker, K Vaidya, BJ Cochran, S Patel - Cells, 2021 - mdpi.com
Periprocedural myocardial injury and myocardial infarction (MI) are not infrequent
complications of percutaneous coronary intervention (PCI) and are associated with greater …

[HTML][HTML] Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction

J Mazhar, M Mashicharan, A Farshid - IJC Heart & Vasculature, 2016 - Elsevier
Abstract Background No-reflow (TIMI< 3) during primary PCI (PCI) for STEMI occurs in 11–
41% of cases, indicates poor myocardial tissue perfusion, and is associated with a poor …